Amgen Announces Top-Line Results from Phase 3 KYPROLIS® (Carfilzomib) CLARION Study in Patients with Newly Diagnosed Multiple Myeloma Sept. 27, 2016
seen from China
seen from China
seen from United States
seen from United States
seen from Italy
seen from China

seen from United States
seen from China

seen from United States
seen from Bolivia
seen from Latvia
seen from United States
seen from United Kingdom
seen from United States

seen from Maldives
seen from United States

seen from United States
seen from China
seen from Malaysia
seen from United States
Amgen Announces Top-Line Results from Phase 3 KYPROLIS® (Carfilzomib) CLARION Study in Patients with Newly Diagnosed Multiple Myeloma Sept. 27, 2016